A systematic literature review and network meta-analysis feasibility study to assess the comparative efficacy and comparative effectiveness of pneumococcal conjugate vaccines-Reference-Cited by-同舟云学术

A systematic literature review and network meta-analysis feasibility study to assess the comparative efficacy and comparative effectiveness of pneumococcal conjugate vaccines

Published:2019-06-19 Issue:11 Volume:15 Page:2713-2724
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

McGirr Ashleigh¹^ORCID,Iqbal Shehzad M.¹,Izurieta Patricia²,Talarico Carla³,Luijken Janneke⁴^ORCID,Redig Josefine⁵^ORCID,Newson Rachel S.⁴

Affiliation:

1. GSK, Mississauga, Ontario, Canada

2. GSK, Wavre, Belgium

3. GSK, Rockville, MD, USA

4. ICON plc, Houten, The Netherlands

5. ICON plc, Stockholm, Sweden

Funder

GlaxoSmithKline

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://tandfonline.com/doi/pdf/10.1080/21645515.2019.1612667

Reference52 articles.

1. Cohen O, Knoll M, O‘Brien K, Ramakrishnan M, Constenla D, Privor-Dumm L, Buss-Younkin J, Farrar J, Pilishvili T, Whitney C. et al. Pneumococcal Conjugate Vaccine (PCV) product assessment; 2017 [accessed 2017 Sept 30]. https://www.jhsph.edu/ivac/wp-content/uploads/2018/05/pcv-product-assessment-april-25-2017.pdf.

2. Centers for Disease Control. Pneumococcal disease; 2015 [accessed 2017 Sept 30]. https://www.cdc.gov/vaccines/pubs/pinkbook/pneumo.html.

3. World Health Organization. Pneumococcal disease; 2016 [accessed 2017 Sept 30]. http://www.who.int/ith/diseases/pneumococcal/en/.

4. World Health Organization. Immunization, vaccines and biologicals. pneumococcal disease; 2011 [accessed 2017 Sept 30]. http://www.who.int/immunization/topics/pneumococcal_disease/en/.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative efficacy of ofatumumab versus oral therapies for relapsing multiple sclerosis patients using propensity score analyses and simulated treatment comparisons;Therapeutic Advances in Neurological Disorders;2024-01

2. Increasing transparency in indirect treatment comparisons: is selecting effect modifiers the missing part of the puzzle? A review of methodological approaches and critical considerations;Journal of Comparative Effectiveness Research;2023-10

3. A retrospective cohort study investigating the comparative effectiveness of pneumococcal vaccines against hospitalisation with otitis media and pneumonia in New Zealand;Vaccine;2023-06

4. Systematic review of the efficacy, effectiveness and impact of high-valency pneumococcal conjugate vaccines on otitis media;Human Vaccines & Immunotherapeutics;2022-01-12

5. Pneumonia and Invasive Pneumococcal Diseases: The Role of Pneumococcal Conjugate Vaccine in the Era of Multi-Drug Resistance;Vaccines;2021-04-22